Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRISPR
Pharma
NICE signs off on Vertex, CRISPR's Casgevy for beta thalassemia
The cost-effectiveness regulator recommended government funding for the groundbreaking gene editing therapy in one of its two approved indications.
Zoey Becker
Aug 7, 2024 8:20pm
Agilent will pay $925M to acquire specialty CDMO Biovectra
Jul 22, 2024 11:01am
Michigan Medicaid signs deal with bluebird for SCD gene therapy
Mar 11, 2024 11:00am
'The Top Line': Gene editing's next act
Feb 16, 2024 8:55am
Vertex's sales of Trikafta hit $8.9B thanks to label expansion
Feb 6, 2024 12:39pm
J&J lands two cancer drugs on Clarivate list of notable new meds
Jan 17, 2024 1:19pm